Article
Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs
19 Oct 2006
Abstract excerpt
Adult tissue-derived mesenchymal stem cells (MSCs) have demonstrated therapeutic efficacy in treating diseases or repairing damaged tissues through mechanisms thought to be mediated by either cell replacement or secretion of paracrine factors. Characterized, self-renewing human ESCs could potentially be an invariable source of consistently uniform MSCs for therapeutic applications. Here we describe a clinically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
